Jason Mast is a general assignment reporter at STAT focused on the science behind new medicines and the systems and people that decide whether that science ever reaches patients. You can reach Jason ...
Vertex Pharmaceuticals has hit a snag in its efforts to follow up non-opioid pain reliever Journavx (suzetrigine). The Boston-based Big Biotech’s sodium channel inhibitor VX-993 failed to outpace ...
Jupiter Endovascular today announced positive results from the first-in-human study of its Vertex pulmonary embolectomy ...
Jupiter Endovascular, which was formed by Neptune Medical a little more than a year ago, shared positive results from the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback